HPLC Chiral Separation of Tebuconazole Enantiomers on Cyralis AM Column

https://sielc.com/hplc-chiral-method-for-analysis-of-tebuconazole
⬇ PDF Download

Chromatogram

Description

· High Performance Liquid Chromatography (HPLC) Method for Analysis of Tebuconazole .

Tebuconazole is a triazole fungicide with the chemical formula C 16 H 22 ClN 3 O . It is used against to plant pathogenic fungi. Despite the U.S. Food and Drug Administration considering this fungicide safe, it is considered a possible carcinogen with the rating of C. According to the World Health Organization, it has moderate toxicity and is slightly hazardous. You can find detailed UV spectra of Tebuconazole and information about its various lambda maxima by visiting the following link.

This application describes a normal-phase chiral HPLC method for the separation of Tebuconazole enantiomers using SIELC’s Cyralis AM chiral column. Cyralis AM is an amylose-based chiral stationary phase (CSP) designed for enantiomeric separations, optical purity testing, chiral impurity analysis, and stereoisomer characterization in pharmaceutical, chemical, agrochemical, and fine chemical applications.

Tebuconazole can be retained and analyzed using the Cyralis AM stationary phase column. The analysis utilizes an isocratic method with a mobile phase consisting of Hexane, Ethanol, and DEA. Detection is performed using UV.

Method Parameters

Mobile PhaseHexane/Ethanol/DEA
Flow Rate1.0 mL/min
DetectionUV 230 nm
Resolution1.72
Class of CompoundsFungicide
Analyzing CompoundsTebuconazole

HPLC Column Used

Cyralis AM, 4.6 x 250 mm, 5 µm, 100 A, normal phase